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Abstract
The human neuronal apoptosis inhibitory protein (NAIP) gene is no longer principally considered a member of the Inhibitor
of Apoptosis Protein (IAP) family, as its domain structure and functions in innate immunity also warrant inclusion in the Nod-
Like Receptor (NLR) superfamily. NAIP is located in a region of copy number variation, with one full length and four partly
deleted copies in the reference human genome. We demonstrate that several of the NAIP paralogues are expressed, and
that novel transcripts arise from both internal and upstream transcription start sites. Remarkably, two internal start sites
initiate within Alu short interspersed element (SINE) retrotransposons, and a third novel transcription start site exists within
the final intron of the GUSBP1 gene, upstream of only two NAIP copies. One Alu functions alone as a promoter in transient
assays, while the other likely combines with upstream L1 sequences to form a composite promoter. The novel transcripts
encode shortened open reading frames and we show that corresponding proteins are translated in a number of cell lines
and primary tissues, in some cases above the level of full length NAIP. Interestingly, some NAIP isoforms lack their caspase-
sequestering motifs, suggesting that they have novel functions. Moreover, given that human and mouse NAIP have
previously been shown to employ endogenous retroviral long terminal repeats as promoters, exaptation of Alu repeats as
additional promoters provides a fascinating illustration of regulatory innovations adopted by a single gene.
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Introduction
Transposable elements (TEs) are ubiquitous components of
most sequenced genomes, but their function, if any, is poorly
understood. Comprising ,50% of the human genome, the
majority of TEs belong to the short interspersed element (SINE)
(.10%), long interspersed element (LINE) (.20%), and endog-
enous retroviral/long terminal repeat (LTR) (,10%) families [1].
The SINEs encode no open reading frame (ORF) and have
utilized LINE-encoded proteins [2] to amplify to .10
6 copies in
the human and mouse genomes [1,3]. On the other hand, only a
limited number of LINEs and LTR elements are full-length; many
of which are rendered non-functional due to point mutations and
deletions [4]. Therefore, the majority of TEs no longer pose a
significant burden as insertional mutagens, although many retain
the regulatory signals necessary for transcription [5,6].
The LTRs and LINEs naturally harbour RNA polymerase II
(pol II) signals and numerous examples of promoter exaptation by
host genes exist [5,7,8]. On the other hand, SINEs replicate via
pol III [9], and thus are not expected to impose direct regulatory
effects on protein-coding genes. Indeed, SINEs are over-
represented within gene-rich regions, while the LTRs and LINEs
are under-represented [6]. Recent scrutiny of the primate-specific
Alu SINEs has provided various illuminating findings. They can be
incorporated into mRNA as cassette exons [10,11], and are often
found in UTRs [8,9,12]. Furthermore, consensus binding motifs
for many pol II transcription factors have recently been identified
within Alus [13,14], but their role as promoters and enhancers has
not been extensively researched.
We have previously shown that the neuronal apoptosis
inhibitory protein (NAIP) orthologues in human (NM 022892.1)
and mouse (NM 008670.2; NM 021545.1; NM 010870.2; NM
010872.2) provide a remarkable example of LTR promoter
exaptation – unrelated LTRs were independently acquired as gene
promoters [15]. NAIP is a member of the inhibitor of apoptosis
protein (IAP) family, and was cloned as a candidate gene for the
neurodegenerative disorder Spinal Muscular Atrophy (SMA) [16].
Consistent with its role as a modifier of SMA severity, NAIP has
been shown to inhibit programmed cell death by binding activated
caspases [17,18,19]. Moreover, the IAPs have emerged as
therapeutic and diagnostic targets for various cancers [20,21,22].
Furthermore, the effect of NAIP expression in other neurodegen-
erative diseases, such as Alzheimer’s disease, Down syndrome,
multiple sclerosis, and Parkinson’s disease, has also been
investigated [23,24]. Recently, a potential role in innate immunity
surfaced through the discovery that polymorphism of a particular
Naip copy in mouse strains determined permissiveness of Legionella
pneumophila replication in host macrophages [25]. Paradoxically,
Naip-mediated L. pneumophila restriction is caspase 1-dependent and
signaling through this pathway results in the rapid death of
PLoS ONE | www.plosone.org 1 June 2009 | Volume 4 | Issue 6 | e5761infected cells [26,27,28]; a role consistent with its inclusion in the
Nod-Like Receptor (NLR) superfamily of cytosolic pattern
recognition sensors [29].
Here the flexibility associated with NAIP regulation in human is
further demonstrated, by showing that 59 truncated transcripts
arise from two unique Alu SINEs. The resulting ORF is translated
in a number of cell lines and primary tissues, and yields a protein
possessing only the signature NLR domains. Since Alus are over-
represented in gene-rich regions and present transcription factor
binding motifs, their role in establishing transcriptional networks is
of great interest, as previously suggested [13,30]. These findings
indicate, for the first time, that Alu insertions can serve directly as
gene promoters and derive novel transcripts and protein isoforms.
The existence of NAIP protein isoforms, as described here, should
therefore be considered in future experiments addressing its IAP
and/or NLR functions.
Results
Human NAIP is a multicopy gene
Copy number variation (CNV) exists in the region of human
chromosome 5q13.2 encoding NAIP and other genes [31,32,33],
as it does among inbred mouse strains [25]. In the reference
human genome at least five copies are annotated [34] (Figure 1a),
and while only one of these is full length, NAIP
full, the others are
assumed to be pseudogenes since two are 59- and two are 39-
deleted, NAIP1 & 2 and YNAIP1 & 2, respectively (Figure 1a, b).
Exon content of the NAIP paralogues was verified using dot plots
(Figure S1). While assessing their transcription using a variety of
RT-PCR primers sets, we found that 39 transcript levels of NAIP
are greater than 59 transcript levels in most tissues. In general,
NAIP 59 and 39 transcripts showed the smallest differences in the
macrophage-rich lung, spleen (Figure 1c), and blood (Figure S2).
Figure 1. Expression of predicted NAIP copies in the sequenced human genome. A) General landscape of chromosome 5q13.2, including
the NAIP (black arrows), GUSBP1 (grey arrows), and surrounding genes (white arrows). B) Exon architecture of the annotated NAIP copies, verified by
dot plots (Figure S1). Slanted lines delimit deletions relative to NAIP
full. Diagrams are not drawn to scale. C) qRT-PCR with primers indicated by small
arrowheads in panel B to determine the overall levels of NAIP 59 (light bars) vs 39 (dark bars) transcription. Values are normalized to b-actin levels in
each tissue, and shown relative to kidney 59. Each bar represents the mean of at least five independent experiments 6 SD.
doi:10.1371/journal.pone.0005761.g001
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macrophage infiltration [35], the cell type mediating NAIP-
dependent L. pneumophila immunity. The largest difference is
observed in testis where 39 levels are .40-fold above 59 levels.
Interestingly, in liver 59 levels of NAIP are the highest (Figure 1c),
potentially arising from transcription of 39 deleted isoforms,
premature poly-adenylation, or CNV-associated anomaly within
the tissue sample screened. The abundance of 39 transcripts raises
the possibility that the 59 deleted copies, NAIP1 and NAIP2, are
expressed (Figure 1c, Figure S2), or that internal promoters of
NAIP
full produce transcripts lacking the 59 end, or both.
Novel human NAIP transcription start sites
The observation that levels of 59 vs. 39 transcription are not
uniform across various human tissues prompted an analysis to
determine where NAIP transcription was initiating. Previously, we
showed that an upstream ERV-P LTR is a promoter of NAIP
full
specifically in testis, but that ubiquitous expression derives from
within an exon in the 59 UTR [15]. Moreover, a previously
published transcription start site [36], overlaps a MER21C LTR
slightly upstream of the ERV-P, but could not be confirmed by 59
RACE. However, an RT-PCR approach using tiled primers,
similar to that of Xu et al. [36], indicated that an adjacent AluSx
SINE was also included in these transcripts (Figure S3). We are
unable to conclude whether this SINE is in fact a site of NAIP
transcription or an internal exon of an undescribed 59 UTR.
Here we revised our previous 59 RACE approach, which only
assessed the transcription start sites (TSS) associated with
expression of NAIP
full [15], and numerous novel TSS were
discovered (Figure 2). Unexpectedly, we observed that two Alu
SINEs localized 59 of exon 10, an AluSg and AluJb, are sites of
NAIP transcriptional initiation, hereon referred to as NAIP
Sg and
NAIP
Jb (Figure 2a). These Alus are in the antisense orientation, full-
length (,300 bp) and present in NAIP orthologues of New and
Old World primates (data not shown). Since sequence identity
hinders their unambiguous mapping, NAIP
Sg and NAIP
Jb 59 RACE
clones could arise from three of the five copies (NAIP
full, NAIP1,
and NAIP2) in the reference human genome (Figure S4). Thus,
either NAIP1 and/or NAIP2 are expressed from Alus, or these Alus
may serve as promoters within NAIP
full, or both.
A number of NAIP
Sg clones were obtained that mapped to two
distinct TSS localizing in the 39 terminus of the Alu (Figure S4a).
Interestingly, the AluSg A-rich tail is known to be hypermutable
[37,38], however, the corresponding region of this particular
element is identical to its consensus sequence. The upstream
,9 kb (relative to NAIP
Sg polarity) is a patchwork of LINE
fragments and Alus, and likely contributes additional regulatory
signals. All NAIP
Sg clones splice into the adjacent exon 8 (Figure 2a,
Figure S4a), utilizing a splice donor site frequently employed by
exonized antisense Alus [10,11]. Several NAIP
Jb clones were also
obtained, these map to two particular regions localized near the
AluJb 59 terminus (Figure S4b). The regulatory signals comprising
the NAIP
Jb core promoter, therefore, are expected to lie within the
body of this Alu. The NAIP
Jb clones, however, do not splice into the
downstream exon 10, rather transcription continues through the
intervening ‘intron’. The validity of NAIP
Jb transcripts is verified
by +/2 RT controls (Figure S5). Interestingly, the splice donor
sequence utilized by NAIP
Sg has undergone an AGRAT
transversion mutation in NAIP
Jb (Figure S4b); its capacity for
splicing has not been studied here. Additional TSS downstream of
NAIP
Jb, in the intervening sequence adjacent exon 10, are also
observed (Figure S4b).
Another site of transcription initiation was identified within the
final intron of the GUSBP1 gene (Figure 2a). Although sequence
identity hinders unambiguous mapping of this transcript, the novel
first exon splices into exon 4 of the adjacent NAIP1 and/or NAIP2.
Consequently, expression of at least one other NAIP copy, in
addition to NAIP
full, is demonstrated since a TSS within the final
intron of the GUSBP1 gene is only adjacent to NAIP1 and NAIP2.
Promoter activity of proximal NAIP
Sg and NAIP
Jb
sequences
Particularly intrigued by the Alu TSS, we tested the capacity of
the underlying sequences as pol II promoters in reporter gene
assays, relative to the 59 promoters we previously identified [15].
Indeed, the ubiquitous NAIP
full and LTR-derived, testis-specific
NAIP
ERV-P are capable promoters in the NTera2D1, HeLa
(Figure 2b), and Jeg3 (data not shown) cell lines. A .500 bp
DNA fragment underlying the NAIP
Jb TSS, including the ,200 bp
of upstream Alusequence and extending59 towardexon 10,exhibits
strong promoter activity (Figure 2b). Similarly, a 600 bp fragment
centered on the NAIP
Sg TSS, containing the entire AluSg and the
upstream 300 bp of internal L1 sequence, also exhibits considerable
promoter activity relative to an empty vector control, in fact
comparable to the LTR (Figure 2b). Due to location of the AluSg
TSS, the upstream L1 fragment likely contributes promoter
regulatory motifs, but its position relative to a full-length L1 does
not correspond to the previously described antisense L1 promoter
[7]. Analysis of the nucleotide sequences underlying the NAIP
Sg and
NAIP
Jb TSS revealed the incidence of several putative pol II
regulatory motifs, including: TATA-like boxes, initiator sequences,
and downstream promoter elements (Figure S4) [39]. Accumulating
evidence indicates that numerous pol II transcription factor binding
sites lie within Alu elements [13,14]. Indeed, both NAIP-associated
Alus possess potential AP-1 and retinoic acid- and estrogen response
element binding motifs (Figure S4a,b), in agreement with published
consensus sequences [13].
Variable contribution of Alu-associated NAIP transcripts
in different tissues
To address the contribution of Alu-derived NAIP transcripts to
total NAIP expression, qRT-PCR was performed. Although their
transcription is detected in most tissues screened by RT-PCR
(Figure S5), this approach indicates NAIP
Jb is expressed at levels
similar to or higher compared to NAIP
full in many of the tissues
tested, and is therefore likely an important promoter (Figure 3). In
contrast, NAIP
Sg does not contribute significantly to total NAIP
expression in any tissue tested (Figure 3). Interestingly, scrutiny of
59 RACE sequences revealed that NAIP
Sg undergoes RNA editing
in its 59 UTR (Figure S4a), a common observation among
transcribed Alus [40,41]. Comparison of edited vs. un-edited
NAIP
Sg transcript levels indicated the former is .10-fold more
abundant than the latter (data not shown).
Most NAIP transcription in colon, spleen, lung, and prostate
could be accounted for by the combined activity of all queried
promoters, but the contribution of individual paralogues could not
be assessed due to their high sequence identity. However, in
kidney and testis all isoforms are not detected and it is likely that
unaccounted 39 transcription either initiates downstream of AluJb,
as indicated above (Figure S4b), or from the NAIP
GUSBP1 TSS.
Contribution of NAIP
GUSBP1-derived transcripts could not be
assessed due to the complexity of alternative splicing in this 59
UTR (Figure S5). As discussed previously, the 59 levels of NAIP in
liver are expressed 4-fold over 39 levels, suggesting that all
transcription in this tissue derives from NAIP
full. Since two
independent liver RNA samples were screened, this rules out the
possibility of patient-specific CNV, unless both samples derive
Novel Promoters for Human NAIP
PLoS ONE | www.plosone.org 3 June 2009 | Volume 4 | Issue 6 | e5761Figure 2. Identification of novel NAIP transcription start sites. A) Diagram of transcription start sites identified in the NAIP
full (top) and NAIP1/2
(bottom) copies by 59 RACE. In the center, shaded block arrows indicate polarity of genes encoded on 5q13.2 (as in Figure 1a) and enlargements of
NAIP
full and NAIP1/2 are shown above and beneath this representation. Their orientation is shown opposite to which they are encoded and black
boxes represent exons. Checkered and striped block arrows indicate localization and orientation of Alus and the previously identified NAIP LTR
promoters [15], respectively. Not all repeat elements are shown. Black double arrowheads represent primers used in nested RT-PCR to uncover NAIP
TSS in this and a previous analysis [15], represented by stick diagrams in top- and bottom-most images. All sequenced clones arising from Alus, and
Novel Promoters for Human NAIP
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isoforms that constitutively omit one or both exons to which our 39
qRT-PCR primer sets are designed. Alternatively, NAIP
full
transcripts in this tissue could be aberrantly poly-adenylated.
Regardless, neither NAIP
Sg nor NAIP
Jb are highly expressed in
liver.
Full-length Alu-derived transcripts are broadly expressed
The fact that the AluJb functions as a pol II promoter is an
intriguing finding, with genome-wide ramifications in establish-
ment of transcriptional networks, as previously suggested [13,30].
We next examined the potential for transcription of a novel NAIP
ORF as a result of Alu promoter activity. Indeed, if all downstream
exons are included in at least some Alu-derived NAIP transcripts, a
2,643 nucleotide ORF is preserved (Figure S6). Therefore, we
sought to determine whether Alu-initiated transcripts continue to
the 39 terminus, by RT-PCR. Southern blotting was required
since, by necessity, primers hybridized to Alus – the most plentiful
elements in primate genomes [1]. Across all tissues screened,
except liver, products corresponding to the expected size (,3 kb)
were resolved for NAIP
Jb (Figure 4). Among various minor forms,
one notable variant of ,2 kb is expressed at the same frequency as
full-length NAIP
Jb. This ,2 kb variant, among numerous others
including full-length, is also observed for NAIP
Sg transcripts in
several tissues (data not shown). Potentially the smaller isoform
could result from alternative splicing common to both NAIP
Jb and
NAIP
Sg transcripts, between the site of reverse primer binding and
probe hybridization. Alternatively, a single NAIP transcript
possessing a second exonized Alu downstream of some or all of
the probe-binding region could also explain this observation. The
prominent ,3 and ,2 kb bands do not result from the
simultaneous amplification of NAIP
Jb and NAIP
Sg due to primer
cross-reactivity, since the respective transcripts and their unique 59
UTRs are roughly equal in size. Nonetheless, existence of full-
length Alu-derived transcripts, a potential 2,643 nucleotide ORF,
and numerous in-frame ATGs in accordance with derived
consensus sequences [42,43] (Figure S6) suggest a potential for
the synthesis of NAIP protein isoforms.
Novel human NAIP protein isoforms
Using the annotated copies of NAIP in the sequenced human
genome as a reference [34], we scanned all possible full-length
transcripts that could arise from the novel TSS reported above for
ORFs and domain composition. Many potential ORFs were
identified for each queried transcript, but only the longest
examples were considered. Interestingly, all accepted examples
represented N-terminal truncations of NAIP
full, indicating the
existence of numerous potentially functional in-frame translation
initiation codons (Figure 5a, Figure S6). NAIP
full was previously
shown to comprise 1403 amino acids and yield a ,160 kDa
protein encoding three N-terminal anti-apoptotic Baculoviral IAP
Repeat (BIR) domains, followed by a central nucleotide binding
domain (NBD) and C-terminal leucine-rich repeats (LRR) [16].
NAIP
Sg- and NAIP
Jb-mediated transcription of NAIP2 is predicted
to generate an ORF 881 amino acid long, and corresponds to a
110 kDa protein that excludes the BIRs (NAIP
Alu). Due to the
deletion of exons 12-14 in NAIP1 a C-terminal truncation of the
LRRs is also predicted, in addition to a truncation of its N
terminus (Figure 1b), and could produce a ,85 kDa NAIP protein
isoform, but was not detected. Finally, transcription from the
promoter within the final GUSBP1 intron can drive expression of
both NAIP1 and NAIP2, and potentially gives rise to 100 kDa
(NAIP1) and 130 kDa (NAIP2) proteins, respectively. Both
putative protein isoforms, NAIP1 and NAIP2, possess one N-
Figure 3. Contribution of Alu-initiated isoforms to total NAIP transcription. Expression levels of the targets: NAIP
Total (39), NAIP
full (59), NAIP
Jb,
and NAIP
Sg were normalized to b-actin and are shown relative to 39 levels of NAIP transcription in the indicated tissues. Each bar represents the mean
of at least five independent experiments 6 SD.
doi:10.1371/journal.pone.0005761.g003
neighboring TSS, map with perfect identity to NAIP
full, NAIP1, and NAIP2. B) Novel regulatory regions associated with NAIP transcription. Luciferase
assays were performed using reporter constructs centered on the previously identified ERV-P and NAIP
full, and the NAIP
Sg and NAIP
Jb TSS identified
here (indicated by bent arrows). The fragments tested are denoted by solid bars beneath the magnified NAIP
full image (top), and are labeled
accordingly. Exons, Alus, and LTR elements are indicated as in Figure 2a; here, LINE fragments are indicated as speckled arrows. Values are normalized
to an internal control (Renilla luciferase) and expressed relative to a promoter-less control vector (pGL3-Basic). Each bar represents the mean of at
least four independent experiments 6 SD. Gene diagrams are not drawn to scale.
doi:10.1371/journal.pone.0005761.g002
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NAIP2 harbours C-terminal LRRs. Indeed, western blots on
human PC3, HeLa, and NTera2D1 cell lysates indicate the
presence of multiple bands corresponding to the above computer
predictions (Figure 5b). To more accurately assess the potential for
translation of the Alu-derived NAIP2 ORF we generated a
NAIP:hemagglutinin fusion protein (HA:NAIP
Alu) and over-
expressed it in the cell lines indicated above. The recombinant
protein HA:NAIP
Alu is translated and migrates at 110 kDa with
the putative endogenous isoform (NAIP
Alu) in untransfected PC3
and HeLa cells (Figure 5b). It is clear the NAIP protein isoforms
are differentially expressed in the queried cell lines, but all three
cell lines endogenously produce the ,160 kDa NAIP
full and
,110 kDa NAIP
Alu proteins, albeit to a different degree. In the
PC3 and HeLa cell lines, where HA:NAIP
Alu was overexpressed,
an increase in band intensity is seen compared to NAIP
Alu in
untransfected cells. Overall, expression of the putative NAIP
Alu
protein is low relative to NAIP
full in all cell lines, however, the
difference is not as exaggerated in NTera2D1 cells compared to
PC3 or HeLa. Lastly, it appears that neither NTera2D1 nor HeLa
cells express the putative ,130 kDa NAIP2 protein isoform.
NAIP protein isoforms are broadly expressed in human
tissues
The observation that NAIP proteins equivalent in size to all of
the computer-predicted isoforms are expressed in the cell lines
screened, prompted a similar investigation of primary human
tissues (Figure 6). A variety of NAIP proteins were detected in most
of the tissues examined, although NAIP
full is not broadly
expressed. In fact, NAIP
full was only detected in heart, skeletal
muscle, and at very low levels in testis. Similarly, the ,110 kDa
protein, which is expected to represent the Alu-derived NAIP ORF,
is also only detected in heart and skeletal muscle. Potential NAIP2
proteins at ,130 kDa are observed almost uniformly across the
tissues tested, and could correspond to NAIP
GUSBP1-initiated
transcripts. The subtle variation of the putative NAIP2 proteins,
such as in spleen and heart, could result either from alternative
start codon selection (Figure S6) or alternative splicing of NAIP2
terminal exons. Importantly, all of the tissues screened here, other
than testis, derive from one individual with unknown NAIP copy
number and mRNA expression levels. Nonetheless, we demon-
strate the expression of various human NAIP protein isoforms that
correspond with calculated molecular weights of the ORFs
generated by alternative promoter usage.
Discussion
Transposable elements were initially discovered as important
factors in the regulation of gene expression in maize, and termed
controlling units [44]. This view of TE usefulness was contrasted
by the ‘junk DNA’ hypothesis [45]. In recent times their
practicality has garnered increased attention, particularly as
mobile regulatory modules [5,9,13,30]. Strikingly, TEs are
associated with many evolutionarily constrained regions in
mammalian genomes [46], and many conserved non-coding
elements are reported to function as transcriptional enhancers
[47]. In general, it is difficult to ascertain the extent to which TEs
donate their embedded regulatory signals to cellular genes,
particularly because they can impose their effects over great
distances. However, bioinformatics analyses of human and mouse
genomes indicate a substantial impact of TEs on cellular gene
regulation; as many as 25% of genes possess TEs in their UTRs
[8,48]. Therefore, their influence on increasing the diversity of
mammalian transcriptomes is likely underappreciated.
The LTRs and LINEs, due to the natural presence of RNA pol
II signals, are likely candidates to fulfill a regulatory role for
cellular genes; dozens of known cases confirm their utility as
regulatory modules [5,7,8]. In contrast, the pol III-dependent
SINEs are concentrated in gene dense regions [1,6], but have
largely been neglected as modulators of cellular gene expression.
Recent bioinformatics analyses, however, have revealed the
presence of numerous RNA pol II transcription factor binding
sites and hormone response elements within SINEs [13,14],
substantiating an earlier report [49]. Notably, the primate-specific
Alus – divided into the old AluJ, intermediate AluS, and young AluY
subfamilies – present consensus transcription factor binding sites
distributed in an age-dependent manner [13]. Interestingly,
among all gene-associated Alus on chromosome 21 and 22, older
elements tend to harbour estrogen response elements and AP-1
docking sites, while younger and/or polymorphic Alus are
Figure 4. Expression of full-length NAIP
Jb transcripts across many tissues. At top, a schematic diagram of the 39 terminus of NAIP is shown,
not to scale. Exons are indicated by black boxes, checkered and spotted arrows indicate the polarity of SINEs and LINEs, respectively. Not all repeat
elements are shown. The arrowheads represent primers used to assess full-length NAIP transcription. Due to the high copy number of Alus in the
human genome, the resultant RT-PCR gels were resolved by Southern blotting, with the unique probe shown, across the indicated tissues to reveal
true AluJb-derived NAIP transcripts.
doi:10.1371/journal.pone.0005761.g004
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PLoS ONE | www.plosone.org 6 June 2009 | Volume 4 | Issue 6 | e5761Figure 5. Detection of novel NAIP protein isoforms. A) Diagrams of NAIP
full (top) and NAIP1/2 (bottom) are shown; speckled exons 12–14 are
only encoded by NAIP2 in the reference human genome. The known NAIP TSS are indicated by bent arrows, and computational translation predicts
the domain composition and mass of the resulting ORFs: NAIP
full, NAIP
Alu, NAIP
1/2. NAIP
1 is predicted to encode a ,100 kDa protein, and NAIP
2 is
,130 kDa. The BIRs (Baculoviral IAP Repeat); NBD (Nucleotide binding domain) and LRR (Leucine-rich repeat) domains are indicated by circles,
cylinders, and triangles respectively. B) Western blot of NAIP in PC3, HeLa, and NTera2D1. Endogenous expression of NAIP
full, NAIP
2, NAIP
Alu, and
NAIP
1 (top) and HA-tagged NAIP
Alu (bottom) is shown in transfected and untransfected cells.
doi:10.1371/journal.pone.0005761.g005
Figure 6. Expression of NAIP protein isoforms in primary human tissues. Western blot analysis of a commercial, pre-transferred membrane
with human proteins deriving from the tissues of one adult female, with the exception of testis. NAIP expression is shown at top, and actin levels at
bottom. Mass of bands is indicated at left.
doi:10.1371/journal.pone.0005761.g006
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elements. In addition, important roles in mRNA poly-adenylation
have also been revealed for Alus and other TEs in a variety of
organisms [50,51]. Since Alus number .10
6 copies in the human
genome, are enriched in gene-dense regions, and contain potential
pol II transcriptional regulatory motifs, they could be considered
the most important transcriptional regulators.
For the first time it is shown here that an Alu can function as a
direct promoter for a human gene. More commonly, they and
other SINEs are incorporated into mRNA UTRs and coding
regions as cassette exons [5,8,9,52], facilitated by the presence of
numerous splice donor and acceptor sites in the sense and
antisense orientations [10]. Examples of SINE exaptation as
promoters, however, are limited and represented by a sense B1
[53] and an antisense B2 [54] element in mouse. In human, an
isoform of the p75TNFR gene initiates transcription from an
antisense MIR SINE, with the adjacent AluJo providing an
alternative translation start site [55]. Furthermore, a bioinfor-
matics analysis reports the existence of several unvalidated
antisense Alu-associated TSS [8]. Here, broad transcription of
NAIP isoforms from exapted antisense AluJb and AluSg elements is
demonstrated in a number of tissues, but it is unknown whether
these sequences would also be functional in the sense orientation.
The Sg and Jb exaptations associated with NAIP transcription
belong to older families that exhibit 10% and 15% divergence
from their consensus sequences, respectively. Remarkably, NAIP
Jb-
associated transcripts are more highly expressed than full-length
isoforms in many tissues, but NAIP
Sg levels are at the limit of
detection. We further demonstrate that the Alu-initiated NAIP
transcripts extend to the 39 terminus, and that the associated ORF,
harbouring only NBD and LRRs, is translated in a variety of cell
lines and primary human tissues. Our findings also suggest that the
other predicted novel NAIP proteins are expressed, in addition to
the BIR-less isoform directly assessed here. It is notable that the
tissue blot we screened derives from one adult individual, with the
exception of testis, indicated by the manufacturer as an accidental
fatality. An earlier analysis of pooled primary human tissue
samples using a different antibody, also revealed similar NAIP
protein isoforms that were speculated to arise by alternative
splicing [35]. Nonetheless, the data presented here substantiate
transcriptome analyses that reveal alternative promoter usage as
an important source of alternative mRNAs and proteins [56,57].
The NAIP gene first rose to prominence when it was cloned as a
putative disease allele for the neurodegenerative disorder, Spinal
Muscular Atrophy (SMA) [16], but is now understood to influence
SMA severity, which is induced by the adjacent SMN gene [58].
Its identification did seed discovery of the Inhibitor of Apoptosis
Protein (IAP) family in animals [19]. The IAPs sequester activated
caspases, the agents of cell death, via their signature N-terminal
BIR domains [20]. Interest in NAIP was renewed through the
discovery that polymorphism of the murine Naip5 (Birc1e) copy
solely determines permissiveness of Legionella pneumophila replication
in host macrophages [25]. Human Legionella infections result in
Legionnaire’s disease, a severe type of pneumonia [59]. It was
recently shown that human NAIP also blocks L. pneumophila
replication in cell lines and primary cells, suggesting a common
function [60]. NAIP-dependent sensing of cytosolic microbial
patterns is LRR-dependent, and is currently known to respond to
Legionella and Salmonella typhimurium flagellin [26]. These and other
findings point to an important role in the innate immune response,
and justify the inclusion of NAIP in the NLR superfamily [29].
Invariably, the NLRs possess a central NBD and C-terminal
LRRs; collectively they survey the cytosol for pathogen associated
molecular patterns and elicit the appropriate response [61].
While the potential functions of the novel NAIP protein
isoforms are unknown, there are several possibilities. Firstly, NAIP
proteins are known to homo-oligomerize via their NBD [17],
therefore, expression of BIR-truncated isoforms and their
subsequent interaction with NAIP
full, could be a mechanism
whereby its anti-apoptotic properties are effectively dispersed
among a greater number of cytosolic molecules. Alternatively,
these could be dominant negatives and serve to regulate the
amount of anti-apoptotic NAIP molecules active in a given cell.
Finally, expression of NAIP protein isoforms could represent a
new example of innovation within the innate immune system,
whereby hetero-oligomerization of NLRs creates diversity among
these cytosolic sensors, analogous to the Natural Killer inhibitory
cell receptor repertoire [62]. Indeed, NBD-mediated heterotypic
interactions of some NLRs, including NAIP, have been demon-
strated [63]. Moreover, Naip was also shown to co-precipitate with
its closest homologue, ICE protease activating factor (Ipaf) [27].
Together these proteins activate Interleukin converting enzyme
(ICE or caspase 1), and initiate caspase 1-dependent cell death in
response to cytosolic flagellin [26,27,28]. Although caspase 1 is
required to cleave the inflammatory cytokines proIL-1b and
proIL-18 into their active forms, their involvement in this process
remains unresolved. Interestingly, and perhaps not coincidentally,
the cellular processes affected by IL 1b – proliferation,
differentiation, and apoptosis – are the same as those influenced
by AP-1 transcriptional regulation [64].
Genes involved in immunity tend to permit regulatory variation
[8], as do multicopy genes [52]. While it is known that alternative
59/39 ends create genetic variation that leads to proteome
evolution [56,57,65], the effect of Alu elements is under
appreciated. Here we show that transcription from Alus generates
a novel NAIP ORF that is subsequently translated, clearly
indicating the effect they have on not only gene regulation, and
perhaps establishment of transcriptional networks [13,30], but also
proteome evolution.
Methods
Ethics Statement
The blood sample was obtained with written informed consent
according to a protocol approved by the University of British
Columbia Research Ethics Board.
RNA and Reverse Transcription
With the exception of blood, all human RNA was purchased
from Clontech (Mountain View); each sample consists of pooled
material from multiple individuals. Blood was obtained from a
healthy human adult with informed consent and the sample
subsequently underwent erythrocyte reduction. RNA from
remaining peripheral blood leukocytes (PBLs) was isolated using
the QIAmp RNA Blood Mini Kit (Qiagen). Where necessary,
RNA was isolated from candidate cell lines using TRIzol
(Invitrogen) according to the manufacturer’s recommendations.
Prior to reverse transcription, RNA was quantified using a Qubit
fluorometer (Invitrogen). All cDNA synthesis was prepared by
random hexamer-primed Superscript III Reverse Transcriptase
(Invitrogen), as directed by the manufacturer.
RT-PCR
All RT-PCR, except as indicated below for amplification of the
NAIP ORF and generation of the expression vector, was
performed with Platinum Taq DNA Polymerase (Invitrogen) and
the relevant primers are listed in Table S1, all used at 10 mM.
Optimal primer annealing temperatures were deduced using the
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cycles. Subsequent experiments were carried out at the optimal Tm
for each primer set in a GeneAmp PCR System 9600 (Applied
Biosystems). Discrimination of 59 vs 39 NAIP transcript levels was
carried out at 30 cycles. The full-length NAIP ORF deriving from
the Alu SINEs was obtained by amplification with Phusion High
Fidelity DNA Polymerase (Finnzymes). As expected, primers
within Alu SINEs yielded a multitude of products and were
subsequently resolved by Southern blotting. Probe was generated
with radiolabeled dCTP
32 using the random primer labeling kit
(Invitrogen) as directed. Pre-hybridization, hybridization, and
washes of Zeta-probe GT membranes (BioRad) were performed
using ExpressHyb (Clontech) according to manufacturer’s speci-
fications. Exposure of BioMax Film (Kodak) for one hour or less
was sufficient to adequately differentiate true bands from
background.
59 Rapid Amplification of cDNA Ends
Using the First-choice RLM RACE Kit (Ambion) the 59 termini
of human NAIP were deduced as before [15]. We revised our
initial approach [15] by designing gene-specific reverse primers to
a downstream exon, common to all predicted NAIP copies (primers
listed in Table S1); previously primers could only surmise
expression of NAIP
full. Subtle variations in RT-PCR product size
was observed across a range of Tms (55u–60u) – since the full
complement of NAIP start sites was being queried – therefore, all
unique bands were purified using the QIAquick Gel Extraction
Kit (Qiagen) and cloned into the pGEM-T vector (Promega) prior
to sequencing (McGill University and Ge ´nome Que ´bec Innova-
tion Centre). Importantly, consistent amplification patterns were
observed within a given Tm. We similarly tested mouse kidney
RNA; although we identified novel intraexonic start sites for
mNaip2, qRT-PCR only showed a slight increase (1.2:1) of 39 over
59 ends (data not shown).
Quantitative RT-PCR
The cDNA used for quantitative RT-PCR with Power SYBR
Green PCR Master Mix (Applied Biosystems) in the ABI 7500
Real Time PCR System (Applied Biosystems) was prepared as
above. Primers (10 mM) were determined to amplify equally
efficiently across a broad range of template dilutions by standard
curve (listed in Table S1). The comparative CT method was used
to quantify targets; CT values were normalized to b-actin levels in
each tissue and expressed relative to the indicated target in the
indicated tissues. Experiments were conducted at least four times
for each primer set, with cycling parameters as follow: 50uC,
2 min; 95uC, 10 min; [95uC, 15 s; 60uC, 1 min] X 40 cycles. For
initial experiments, where primer efficiencies were being deter-
mined, dissociation curves and –RT controls were included,
indicating the specificity of amplification and lack of DNA
contamination in template preparations, respectively (data not
shown). Alternative splicing variants posed a problem in primer
design for the NAIP
ERV-P and NAIP
Sg targets. For NAIP
ERV-P we
quantified only one of the variants and estimated that it accounted
for ,40% of all total LTR-derived transcripts, as before [15]. For
NAIP
Sg, we designed primers spanning exon junctions of both
isoforms and combined their proportions.
Generation of constructs
Placental genomic DNA was obtained from the laboratory of
Dr. P. Medstrand (Lund University) and subsequently used to
PCR amplify the NAIP promoter regions and open reading frame
(ORF). Promoter constructs. Testis-specific LTR (or NAIP
ERV-P), the
ubiquitous NAIP
full, and the Alu-derived NAIP
Sg and NAIP
Jb
promoters were amplified by PCR using Phusion High Fidelity
DNA Polymerase (Finnzymes) in an iCycler (BioRad) over 35
cycles, the primers used are listed in Table S1. The respective
products are approximately 500 bp and centered on the
transcription start sites. All primers possessed BglII and HindII
recognition sites to facilitate directional cloning into a modified
pGL3B vector described elsewhere [15]. Sequencing (McGill
University and Ge ´nome Que ´bec Innovation Centre) verified
fidelity of amplified fragments.
Expression vector. The preserved ORF deriving from
NAIP
Sg and NAIP
Jb transcripts was amplified by Phusion High
Fidelity DNA Polymerase (Finnzymes) from human testis cDNA
(as described above) over 35 cycles, primer sequences are indicated
in Table S1. The desired amplicon was isolated using the PureLink
Quick Gel Extraction Kit (Invitrogen) and subsequently dATP-
tailed with Taq DNA Polymerase (Invitrogen) to facilitate cloning
into the pGEM-T vector (Promega). Sequencing not only
confirmed that the ORF was cloned error-free, but also that
NAIP2 is expressed, in addition to NAIP
full, on account of a single
representative nucleotide difference. Xho1 and Nco1 recognition
sites incorporated into primers were utilized to subclone the
sequenced ORF into the CTV 211 hemagglutinin (HA) epitope-
bearing mammalian expression vector, generously provided by Dr.
R. Kay (Terry Fox Laboratory). All vectors were amplified in E.
coli DH5a and purified using the Nucleobond AX (Clontech) maxi
prep kit, and quantified using the Qubit fluorometer (Invitrogen).
Cell culture and transient transfection
HeLa, NTera2D1, LNCaP, and Jeg3 cells were cultured in
DMEM (Stem Cell Technologies) and PC3 cells in RPMI 1640
(Stem Cell Technologies), and incubated at 37u and 5% CO2. All
media formulations were supplemented with 10% Fetal Bovine
Serum (Invitrogen) and maintained in penicillin/streptomycin,
except when undergoing transfection experiments. Prior to
transfection of promoter constructs cells were seeded at 10
5
cells/well, or 2610
5 cells/well for NTera2D1, in a 24-well dish
overnight. Lipofectamine 2000 (Invitrogen) was used to transfect
the indicated cells with the indicated vectors according to
manufacturer’s specifications. Approximately 6-8 hours post-
transfection cells were washed with PBS (Stem Cell Technologies)
and fresh complete media was added to allow for production of the
reporter for an additional ,24 hours. The HA:NAIP expression
vector, was transiently transfected into HeLa, PC3, and
NTera2D1 cells using Metafectene (Biontex) as recommended
by the manufacturer.
Reporter gene assays
Prior to lysis, cells were washed with PBS, processed, then
analyzed for firefly and Renilla luciferase activity using the Dual
Luciferase Reporter Assay System (Promega) as indicated by the
manufacturer. All values were standardized to the Renilla luciferase
internal control to normalize for transfection efficiency, then
expressed relative to the modified promoterless pGL3-Basic
vector.
Western blotting
Cells were grown in 10 cm dishes as indicated above. The
human PC3, NTera2D1, and HeLa cell lines were selected to
screen for NAIP proteins based on preliminary RT-PCR findings
(data not shown). Cells transfected with the expression vector
encoding the Alu-derived NAIP ORF or untransfected controls
were harvested by either scraping or trypsinization following two
washes with cold PBS. Cell pellets were obtained by centrifugation
and resuspended in RIPA (150 mM NaCl; 1% NP-40; 0.5%
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(150 mM NaCl; 1% NP-40; 50 mM Tris, pH8) lysis buffers
supplemented with a protease inhibitor cocktail (Roche), and
subsequently quantified using the Qubit Fluorometer (Invitrogen).
Hemagglutinin epitope signal was easier to detect in NP40 lysates,
while RIPA provided clearer results for the NAIP-specific
antibody. Bi-phased gels containing TEMED and APS (4%
stacking, 9% separating) were used to resolve total cellular protein
in electrophoresis running buffer (106: 25 mM Tris; 192 mM
glycine; 0.1% SDS). Subsequently, separated proteins were
transferred using a Hoefer TE 22 tank transfer unit (Amersham
Biosciences) onto Immobilon-P PVDF membrane (Millipore) in
fresh transfer buffer (25 mM Tris, 192 mM glycine, 10%
methanol, 0.1% SDS). To assess NAIP protein isoforms in
primary human tissues an IMB-103-50 Instablot membrane was
purchased from Imgenex (San Diego). Blocking of all membranes
was performed in 5% reconstituted skim milk powder under
constant agitation at 4u overnight. The following morning,
blocking solution was replaced and fresh primary antibodies were
applied at 1:1000 NAIP (Abcam), 1:3500 Actin (Sigma), and
1:3500 HA (BAbCO) for one hour at room temperature under
constant agitation. Washes were carried out with TBS-T (106:
20 mM Tris;1.4 M NaCl;1% Tween-20) at room temperature in
5 minute intervals, no more than five times. Secondary antibody
was diluted in fresh TBST and 1% blocking solution to a final
concentration of 1:100 000, and incubated for one hour at room
temperature under constant agitation. Washes were conducted as
above. Proteins were detected using the Enhanced Chemilumi-
nescence Kit (Perkin Elmer) and Kodak BioMax Film and
cassettes (Kodak). Where necessary the Instablot was stripped
with 0.2 M NaOH, all other membranes were cleared by an acidic
strip solution (25 mM glycine-HCl pH2, 1% SDS).
Computational tools
Dot plots. Analysis of the underlying DNA sequence of 5q13.3
was performed to better understand the exons mapping to particular
NAIP copies. DNA sequences were obtained from the UCSC Human
Genome Browser March 2006 (hg18) assembly [34]. The genomic
sequence of NAIP
full (chr5:70,298,269-70,360,000) was used to assess
exon architecture of the remaining copies: NAIP1 (chr5:70,425,120-
70,469,539); NAIP2 (chr5:69,424,009-69,495,811); and yNAIP1 and
2 (chr5:69,780,634-69,828,298; 68,921,612-68,967,595). Indicated
sequences were compared using the web-based jdotter (http://
athena.bioc.uvic.ca/workebnch.php?tool+jdotter&db=). Sequence
Analysis. Sequenced clones were uploaded, managed, and analyzed
in the SDSC Biology Workbench (http://workbench.sdsc.edu).
Precise mapping of the clones to the human genome was
completed using the BLAT tool in the UCSC Genome Browser
[34]. ORF prediction. Sequences of interest were scanned for open
readingframesusingNCBI’sORFFinder,andsubsequentanalysisof
encoded domains was completed with BLASTP.
Supporting Information
Figure S1 Homology of human NAIP copies. Dot plots were
performed to better understand the exon architecture of each
NAIP copy. The NAIPfull copy in the 2006 assembly of the human
genome (70,298,269–70,360,000) was compared to the genomic
sequence underlying the other NAIP copies (as indicated). The
coordinates of tested sequences are shown.
Found at: doi:10.1371/journal.pone.0005761.s001 (4.44 MB TIF)
Figure S2 Unequal levels of NAIP 59 and 39 transcription. Semi-
quantitative RT-PCR was performed at a low cycle number across
a panel of human tissues to determine the levels of NAIP 59 and 39
transcription. Red arrowheads indicate localization of the primers
used in this experiment, and are shown relative to a diagram of
NAIPfull, at bottom.
Found at: doi:10.1371/journal.pone.0005761.s002 (7.43 MB TIF)
Figure S3 Analysis of NAIPfull transcription. A) NAIPfull-
associated TSS are shown (bent arrows) as previously described:
i and ii [15]; and iii [36]. Black boxes indicate exons, and labeled
boxes represent LTRs (shaded) and SINEs (speckled). Colored
arrowheads indicate tiled primers used to better understand the
TSS associated with NAIPfull transcription in THP1 cells [36]. B)
Tiled-primer experiments in the indicated primary human tissues
and cell lines. The primers used are color-coded with those shown
above (A). Primary tissues were Southern blotted to increase
resolution, using a radio-labeled oligonucleotide specific for a
region of exon 1 common to all isoforms.
Found at: doi:10.1371/journal.pone.0005761.s003 (10.09 MB
TIF)
Figure S4 Sequence analysis underlying NAIP transcription start
sites for the novel NAIPSg (A), NAIPJb (B), and NAIPGUSBP1 (C)
regulatory regions. cDNA sequence is shown in capitalized letters
and the underlying genomic DNA (gDNA) is shown in lower case.
Subscript numbers associated with green (Alu) or purple (L1) font in
the gDNA track denote positions along the relevant transposable
element. All discovered transcription start sites are indicated in
black bold-face, and superscript numbers in B and C represent the
number of clones arising from the particular position. Vertical
dashed lines in A, B, and C represent exon junctions, and slight
extension of gDNA underlying exon junctions indicates the
appropriate splice donor and acceptor sites. Splicing of NAIPJb
clones does not occur and transcription proceeds through
intervening intron 9 into exon10. Red bold-faced letters in A and
B indicate sites of RNA-editing. Potential regulatory motifs are
shown relative to the lower case genomic DNA sequences as follow:
TATA box - italics; Initiator sequences - overlines; Downstream
promoter elements - underlines [39]; yellow, light blue, and dark
blue shading denote estrogen response element, retinoic acid
response element, and AP-1 binding motifs, respectively [13].
Found at: doi:10.1371/journal.pone.0005761.s004 (0.05 MB
DOC)
Figure S5 Broad transcription of novel NAIP isoforms. RT-PCR
was performed to determine the breadth of expression of NAIP
from the Alu and GUSBP1 39 UTR-contained TSS, represented by
bent arrows. Color-coded arrows indicate the primers used:
expression from NAIPSg is indicated by blue arrows and box;
expression from NAIPGUSBP1 is indicated by purple arrows and
box; and expression from NAIPJb is indicated by orange arrows
and box. No splicing is observed between the AluJb transcription
start site and the adjacent downstream exon; +/2 RT controls
indicate low, or no, contamination of genomic DNA. Diagrams
are not drawn to scale.
Found at: doi:10.1371/journal.pone.0005761.s005 (7.82 MB TIF)
Figure S6 NAIP protein sequence and encoded domains. The
protein sequence of NAIP
full is shown, and exon boundaries are
indicated by numbers above circled arrows. Potential downstream
in-frame initiation codons are indicated in red font, and the
surrounding nucleotide sequence is shown beneath, with ‘atg’ in
boldface. Underlines represent start codons with a sequence
context in general agreement with derived consensi [42,43]. The
stop codon is denoted by an asterisk. Yellow, purple, and green
highlighting indicates BIR, NBD, and LRR domains, respectively.
Found at: doi:10.1371/journal.pone.0005761.s006 (0.03 MB
DOC)
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throughout this investigation is sectioned according to the general
application for which they were designed. Associated with each
primer is the sequence, the Tm at which it was utilized, as well as a
note specifying its particular application.
Found at: doi:10.1371/journal.pone.0005761.s007 (0.07 MB
XLS)
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